NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells 39,816 Shares

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the eleven analysts that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and nine have given a buy […]

NewAmsterdam Pharma (NASDAQ:NAMS) CAO Sells 39,816 Shares

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS – Get Free Report) CAO Louise Frederika Kooij sold 39,816 shares of the firm’s stock in a transaction dated Tuesday, January 27th. The shares were sold at an average price of $32.62, for a total value of $1,298,797.92. Following the transaction, the chief accounting officer directly owned 24,353 shares in […]